Profil
Oliver Dick is currently the Chief Operating Officer at Resolve BioSciences GmbH since 2021.
Prior to this, he worked as the Chief Operating Officer at Miltenyi Biotec Norden AB.
Postes actifs de Oliver Dick
| Sociétés | Poste | Début |
|---|---|---|
Resolve BioSciences GmbH
 Resolve BioSciences GmbH BiotechnologyHealth Technology Resolve BioSciences GmbH is a German company that applies molecular cartography to provide scientists with a high-resolution view of spatial biology. The company is based in Monheim am Rhein, Germany. The company's proprietary technology offers full spatial context at subcellular resolution, which helps scientists detect individual transcripts and rare signals to interpret fundamental biology. The company's technology is used in critical fields such as oncology, neuroscience, infectious disease, and agriculture. The company was founded by Jason T. Gammack, and John Stark has been the CEO of the company since 2023. | Directeur des opérations | 01/12/2021 |
Anciens postes connus de Oliver Dick
| Sociétés | Poste | Fin |
|---|---|---|
| Miltenyi Biotec Norden AB | Directeur des opérations | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
| Miltenyi Biotec Norden AB | |
Resolve BioSciences GmbH
Resolve BioSciences GmbH BiotechnologyHealth Technology Resolve BioSciences GmbH is a German company that applies molecular cartography to provide scientists with a high-resolution view of spatial biology. The company is based in Monheim am Rhein, Germany. The company's proprietary technology offers full spatial context at subcellular resolution, which helps scientists detect individual transcripts and rare signals to interpret fundamental biology. The company's technology is used in critical fields such as oncology, neuroscience, infectious disease, and agriculture. The company was founded by Jason T. Gammack, and John Stark has been the CEO of the company since 2023. | Health Technology |
